Take the program revenue. Then know what the week actually made.
EnlivenHealth and Outcomes bring pharmacies something no owner can build alone: payer relationships, program volume and patient engagement at national scale. Take both. EnlivenHealth describes itself as a division of Omnicell, and Outcomes is a separate company, Outcomes Operating, Inc. What we add sits underneath the channel: what the drugs cost, which fills adjudicated below that cost, and where the audit exposure is.
Networks and payer relationships an individual pharmacy cannot build alone.
Outcomes pays pharmacies real money through its network
Outcomes publishes that it paid pharmacies $181 million in 2024 and $190 million in 2025 for medication therapy management and clinical services, and describes connecting payers, pharma and providers through what it calls the largest network in pharmacy. Those are their published figures, and that is money arriving at community pharmacies through a channel none of them could have negotiated individually.
Patient engagement built over decades
EnlivenHealth states it is a division of Omnicell serving over 35,000 pharmacies, with outreach coordinated across text, voice, email and mobile, personalized adherence reminders, and inbound calls handled automatically with patients identified and routed with context. Its lineage runs through Ateb, FDS Amplicare and MarkeTouch. Outcomes separately markets automated and patient-driven medication synchronization, cloud-based interactive voice response and two-way messaging.
Clinical opportunity identification, which is genuinely useful
EnlivenHealth describes a workflow where the system finds patients who qualify for clinical services, enables joint booking and electronic documentation, and states that documentation and billing happen in one workflow. Knowing which of your patients is eligible for what is a real capability, and it sits upstream of everything else.
Established pharmacy footprint
Outcomes owns pharmacy management systems outright, including Rx30, Computer-Rx and TelePharm, and publishes network figures of over 70 million patients and 48,000 pharmacies. If you already run one of their dispensing systems, the integration question is answered before you ask it.
Revenue in is one number. Revenue kept is the other.
A clinical program network brings you opportunities with a payer already attached, and that is worth having. It raises revenue in. What decides whether the pharmacy survives the year is revenue kept: what the drugs cost, which fills adjudicated below that cost, what an audit letter would cost you to answer, and how well you bought. Those answers live in the claim, the invoice, the encounter and the evidence, held together in one system and subtracted from each other. Take the program revenue, and know your own numbers underneath it.
Complementary, and worth being precise about how.
Figures in the right-hand column are published by these companies about themselves. These are two separate companies, so each cell names which one it refers to.
| Capability | Attergo | EnlivenHealth and Outcomes |
|---|---|---|
| Payer-sponsored clinical program network | No. We do not operate a program network. | Yes. Outcomes publishes $181M in 2024 and $190M in 2025 paid to pharmacies for MTM and clinical services. |
| Patient outreach and adherence communication | No. Patient engagement is theirs. | Yes. EnlivenHealth coordinates outreach across text, voice, email and mobile with adherence reminders. Outcomes markets IVR and two-way messaging. |
| Medication synchronization | No. | Yes at Outcomes, which markets automated and patient-driven medication synchronization. |
| Identifying patients eligible for clinical services | Billable encounters are caught as they happen. | Yes at EnlivenHealth, which states the system finds the patients who qualify for clinical services. |
| Clinical documentation and billing in one workflow | Yes. Encounter to 837P to 835, with documentation checked before submission. | Yes at EnlivenHealth, which states documentation and billing happen in one workflow. |
| Per-fill margin against acquisition cost | Yes, seconds after adjudication, against your own invoice, with the cost source labeled. | Not stated by either company. |
| PBM audit evidence and response packages | Yes, assembled continuously and exported per claim. | Not stated by either company. |
| Purchasing, dead stock and DSCSA | Yes. | Not stated by either company. |
| Owned dispensing systems | None. We integrate with yours and never ask you to change it. | Outcomes owns Rx30, Computer-Rx and TelePharm. |
Every entry in the EnlivenHealth and Outcomes column is drawn from the pages listed at the foot of this page. Where their own materials do not state a capability, the cell says so rather than guessing.
Two honest recommendations.
Choose EnlivenHealth and Outcomes if
you want the program revenue and the patient engagement, which most pharmacies should. Joining a clinical program network is close to free money for work you are already positioned to do, and if you run Rx30 or Computer-Rx the Outcomes relationship is doing useful things for you before you decide anything. Adherence outreach and medication synchronization also lift dispensing volume in a way no analytics product does. Take both.
Choose Attergo if
you have the channel and still cannot answer whether the week made money. The channel raises revenue in. Knowing what you kept needs the claim, the invoice, the encounter and the evidence held together in one place, which is what we do. It runs alongside a program network without touching it, and nothing about adding us changes your program participation or your patient outreach.
The capability that carries most of this weight on our side is Intelligence, and it is one of eight on a single connection.
Every claim above traces to their own words.
- EnlivenHealth, Our Story: "EnlivenHealth is a division of Omnicell, Inc.", lineage and pharmacy count
- EnlivenHealth, Patient Solutions: multi-channel outreach, adherence reminders and automated call routing
- EnlivenHealth, Clinical Solution: eligibility identification, joint booking, documentation and billing in one workflow
- Outcomes homepage: medsync, IVR, two-way messaging and the amounts paid to pharmacies in 2024 and 2025
- Outcomes, About Us: Outcomes Operating, Inc. and its constituent brands
- Outcomes press release, 10 July 2023: the TDS and Outcomes combination and Cardinal Health minority stake
What we could not verify
We could not verify any corporate relationship between EnlivenHealth and Outcomes, so we state only what each company states about itself and assert no transaction between them. We found no medication synchronization claim on EnlivenHealth pages and do not attribute one to them. Neither company publishes pricing, names specific payers or payer-sponsored programs, or names third-party pharmacy management system integrations, so we make no claim on any of those points.
Keep the channel. Add the numbers underneath it.
Thirty minutes, one facility, a read-only connection and credentials you can revoke. We come back with what your own last month actually cost you.
Comparison based on publicly available information as of 2 August 2026. Tell us if something here is out of date and we will fix it. sales@attergo.com